Two NFATc2-related axes control cancer progression: the NEDD4/FBP1 axis in cholangiocarcinoma [29] and the MYC/NFATc2 axis in acute myeloid leukemia (AML) cells [30]. This evidence concerns the gene NFATC2 and cancer.